EV therapeutics have emerged as a pivotal player in the dynamic landscape of cell and gene therapy (CGT). However, the pressing question of how we translate this cutting-edge science into therapeutic reality remains unanswered. The 2025 ISCT Exosomes Scientific Signature Series event will breakdown this question and leverage global expertise to build consensus that will drive development.
This event will bring together a selection of invited subject matter experts from across the translational pathway to identify through a series of discussions what is needed to move EV therapeutics towards clinical translation. Researchers, regulators, investors, and experts in EV and CGT translation will take a multidisciplinary approach to work towards solutions that will shape the future of the field.
Join us for front-row access to pivotal discussions, where experts will collaboratively address the most pressing challenges in the field to advance the translation of EV therapeutics.